Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.
Saved in:
| Title: | Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach. |
|---|---|
| Authors: | Sundheimer JK; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany. j.sundheimer@kitz-heidelberg.de.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany. j.sundheimer@kitz-heidelberg.de.; Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld 234, 69120, Heidelberg, Germany. j.sundheimer@kitz-heidelberg.de., Benzel J; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Federico A; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Volz S; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Knoll M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Statz B; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Zheng T; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Kmiecik SW; Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Burhenne J; Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Bajraktari-Sylejmani G; Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Scheuermann S; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of General Pediatrics, Hematology and Oncology, University Children's Hospital Tuebingen, Tübingen, Germany.; University of Tuebingen, iFIT Cluster of ExCellence (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Tübingen, Germany.; German Cancer Research Consortium (DKTK), Partner Site Tuebingen, German Cancer Research Center (DKFZ), Heidelberg, Germany., King A; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Müller T; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hübner JM; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany., Kalxdorf M; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Peterziel H; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120, Heidelberg, Germany., Oehme I; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120, Heidelberg, Germany., Krijgsveld J; Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seitz CM; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kool M; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology and University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.; Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120, Heidelberg, Germany., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.; Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120, Heidelberg, Germany., Maaß KK; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.; Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. |
| Source: | Scientific reports [Sci Rep] 2026 Apr 10; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
